Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prehypertension | 5 | 2012 | 63 | 1.790 |
Why?
|
Prediabetic State | 4 | 2012 | 546 | 1.010 |
Why?
|
Blood Vessel Prosthesis | 8 | 2020 | 951 | 0.940 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2019 | 1228 | 0.850 |
Why?
|
Blood Vessel Prosthesis Implantation | 8 | 2020 | 1425 | 0.790 |
Why?
|
Nitrobenzenes | 2 | 2012 | 65 | 0.790 |
Why?
|
Endovascular Procedures | 10 | 2020 | 2181 | 0.770 |
Why?
|
Methemoglobinemia | 2 | 2012 | 44 | 0.770 |
Why?
|
Chitosan | 1 | 2023 | 131 | 0.770 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 247 | 0.710 |
Why?
|
Nitrogen | 4 | 2017 | 345 | 0.700 |
Why?
|
Gene Expression Regulation, Plant | 5 | 2014 | 211 | 0.670 |
Why?
|
Hospital Planning | 1 | 2018 | 22 | 0.630 |
Why?
|
Flowers | 3 | 2014 | 31 | 0.610 |
Why?
|
Stents | 9 | 2020 | 3177 | 0.600 |
Why?
|
Tracheotomy | 1 | 2019 | 167 | 0.600 |
Why?
|
Genes, Plant | 3 | 2014 | 128 | 0.600 |
Why?
|
Orchidaceae | 2 | 2014 | 4 | 0.590 |
Why?
|
Eleusine | 2 | 2014 | 2 | 0.560 |
Why?
|
Pollination | 2 | 2013 | 4 | 0.530 |
Why?
|
Nitrates | 2 | 2019 | 260 | 0.530 |
Why?
|
Blood Pressure | 9 | 2015 | 8479 | 0.520 |
Why?
|
Models, Educational | 1 | 2019 | 373 | 0.520 |
Why?
|
Eugenol | 1 | 2014 | 10 | 0.480 |
Why?
|
Disaster Planning | 2 | 2018 | 557 | 0.480 |
Why?
|
Cyclosporine | 1 | 2017 | 776 | 0.480 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.470 |
Why?
|
Operating Rooms | 2 | 2018 | 790 | 0.470 |
Why?
|
Fatigue | 1 | 2021 | 1550 | 0.450 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 173 | 0.430 |
Why?
|
Silene | 1 | 2012 | 1 | 0.420 |
Why?
|
Anisoles | 1 | 2012 | 6 | 0.420 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 488 | 0.410 |
Why?
|
Eucommiaceae | 1 | 2011 | 4 | 0.400 |
Why?
|
Plant Bark | 1 | 2011 | 9 | 0.400 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2420 | 0.390 |
Why?
|
Mexican Americans | 1 | 2012 | 164 | 0.380 |
Why?
|
Volatile Organic Compounds | 1 | 2012 | 86 | 0.380 |
Why?
|
Phentermine | 1 | 2011 | 31 | 0.380 |
Why?
|
Sclerostomy | 1 | 2011 | 16 | 0.370 |
Why?
|
Anti-Obesity Agents | 2 | 2011 | 227 | 0.360 |
Why?
|
Alkylating Agents | 1 | 2011 | 133 | 0.350 |
Why?
|
Femur Neck | 1 | 2012 | 316 | 0.350 |
Why?
|
Plant Proteins | 4 | 2013 | 374 | 0.350 |
Why?
|
Mitomycin | 1 | 2011 | 263 | 0.340 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2018 | 5666 | 0.340 |
Why?
|
Aortography | 4 | 2019 | 421 | 0.340 |
Why?
|
Nitric Oxide | 3 | 2016 | 2137 | 0.340 |
Why?
|
Methyltransferases | 1 | 2012 | 364 | 0.330 |
Why?
|
Vitamin D | 3 | 2012 | 3301 | 0.330 |
Why?
|
Phytotherapy | 1 | 2011 | 296 | 0.330 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 517 | 0.330 |
Why?
|
Circadian Rhythm | 2 | 2011 | 2569 | 0.330 |
Why?
|
Thiazolidinediones | 2 | 2010 | 460 | 0.330 |
Why?
|
Sclera | 1 | 2011 | 189 | 0.330 |
Why?
|
Iliac Vein | 2 | 2020 | 70 | 0.330 |
Why?
|
Glutathione | 1 | 2012 | 581 | 0.320 |
Why?
|
Lymphoma | 1 | 2018 | 1898 | 0.320 |
Why?
|
Hypertension | 5 | 2012 | 8536 | 0.320 |
Why?
|
Energy Intake | 3 | 2016 | 2133 | 0.310 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 410 | 0.300 |
Why?
|
Body Composition | 3 | 2016 | 2427 | 0.300 |
Why?
|
Body Weight | 5 | 2015 | 4618 | 0.300 |
Why?
|
Plant Extracts | 1 | 2011 | 496 | 0.300 |
Why?
|
Terrorism | 3 | 2015 | 210 | 0.290 |
Why?
|
Lomustine | 2 | 2018 | 60 | 0.290 |
Why?
|
Antihypertensive Agents | 3 | 2012 | 2019 | 0.280 |
Why?
|
Body Mass Index | 9 | 2017 | 12952 | 0.280 |
Why?
|
Metformin | 2 | 2018 | 910 | 0.280 |
Why?
|
Weight Loss | 6 | 2013 | 2680 | 0.270 |
Why?
|
Trauma Centers | 4 | 2018 | 938 | 0.270 |
Why?
|
Cardiovascular Diseases | 6 | 2013 | 15521 | 0.270 |
Why?
|
Blood Glucose | 6 | 2015 | 6392 | 0.260 |
Why?
|
Etoposide | 2 | 2018 | 635 | 0.250 |
Why?
|
Waist Circumference | 4 | 2014 | 933 | 0.250 |
Why?
|
Weight Gain | 2 | 2013 | 2349 | 0.250 |
Why?
|
Surgical Wound Infection | 3 | 2023 | 1530 | 0.250 |
Why?
|
Middle Aged | 48 | 2023 | 220858 | 0.250 |
Why?
|
Endothelium, Vascular | 3 | 2015 | 4420 | 0.250 |
Why?
|
Hip Joint | 1 | 2012 | 1014 | 0.250 |
Why?
|
Cytarabine | 2 | 2018 | 697 | 0.240 |
Why?
|
Plant Leaves | 3 | 2016 | 150 | 0.240 |
Why?
|
Prosthesis Design | 7 | 2020 | 2114 | 0.240 |
Why?
|
Bombs | 2 | 2015 | 73 | 0.240 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 3089 | 0.230 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7407 | 0.230 |
Why?
|
Prognosis | 5 | 2023 | 29688 | 0.230 |
Why?
|
Glaucoma, Open-Angle | 1 | 2011 | 739 | 0.230 |
Why?
|
Female | 61 | 2023 | 392552 | 0.220 |
Why?
|
Adipose Tissue | 3 | 2013 | 3313 | 0.220 |
Why?
|
Adiposity | 5 | 2015 | 1879 | 0.220 |
Why?
|
Male | 62 | 2020 | 360703 | 0.220 |
Why?
|
Intuition | 1 | 2023 | 20 | 0.210 |
Why?
|
Wounds, Nonpenetrating | 3 | 2014 | 808 | 0.210 |
Why?
|
Heart Rate | 2 | 2011 | 4197 | 0.210 |
Why?
|
Lumbar Vertebrae | 1 | 2012 | 1876 | 0.200 |
Why?
|
Osteoporosis | 1 | 2012 | 1604 | 0.200 |
Why?
|
Humans | 82 | 2023 | 761222 | 0.200 |
Why?
|
Obesity | 6 | 2013 | 12940 | 0.200 |
Why?
|
Endoleak | 2 | 2020 | 111 | 0.190 |
Why?
|
Subcutaneous Fat, Abdominal | 3 | 2014 | 91 | 0.190 |
Why?
|
Inflammation | 6 | 2016 | 10759 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3610 | 0.190 |
Why?
|
Molecular Sequence Annotation | 2 | 2014 | 518 | 0.190 |
Why?
|
Adult | 35 | 2020 | 221120 | 0.190 |
Why?
|
Methylene Blue | 2 | 2012 | 155 | 0.190 |
Why?
|
Cyclophosphamide | 2 | 2018 | 2219 | 0.190 |
Why?
|
Bandages | 1 | 2023 | 269 | 0.190 |
Why?
|
Antidotes | 2 | 2012 | 138 | 0.180 |
Why?
|
C-Reactive Protein | 5 | 2016 | 3821 | 0.180 |
Why?
|
Adiponectin | 3 | 2011 | 1107 | 0.180 |
Why?
|
Factitious Disorders | 1 | 2020 | 39 | 0.180 |
Why?
|
Liver | 3 | 2012 | 7512 | 0.180 |
Why?
|
Heart Diseases | 2 | 2013 | 2795 | 0.170 |
Why?
|
Iliac Aneurysm | 1 | 2020 | 37 | 0.170 |
Why?
|
Transplantation Conditioning | 2 | 2018 | 1591 | 0.170 |
Why?
|
Treatment Outcome | 24 | 2020 | 64681 | 0.170 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 41 | 0.170 |
Why?
|
DNA, Complementary | 2 | 2014 | 1989 | 0.170 |
Why?
|
Risk Factors | 22 | 2023 | 74241 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.170 |
Why?
|
Nutrition Surveys | 3 | 2012 | 1723 | 0.170 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2018 | 1372 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13367 | 0.170 |
Why?
|
Hodgkin Disease | 2 | 2018 | 1379 | 0.160 |
Why?
|
Bupropion | 2 | 2013 | 304 | 0.160 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 625 | 0.160 |
Why?
|
Bone Density | 1 | 2012 | 3546 | 0.160 |
Why?
|
Naltrexone | 2 | 2013 | 317 | 0.160 |
Why?
|
Celiac Artery | 1 | 2018 | 65 | 0.160 |
Why?
|
Young Adult | 15 | 2020 | 59222 | 0.160 |
Why?
|
Fatal Outcome | 3 | 2012 | 1838 | 0.160 |
Why?
|
Psychophysiologic Disorders | 1 | 2020 | 223 | 0.160 |
Why?
|
Iliac Artery | 1 | 2020 | 343 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9417 | 0.160 |
Why?
|
Embolic Protection Devices | 1 | 2018 | 42 | 0.150 |
Why?
|
Plant Roots | 2 | 2016 | 117 | 0.150 |
Why?
|
Ascorbic Acid | 2 | 2012 | 654 | 0.150 |
Why?
|
India | 3 | 2020 | 2287 | 0.150 |
Why?
|
Cytokines | 3 | 2018 | 7386 | 0.150 |
Why?
|
Time Factors | 15 | 2020 | 39957 | 0.150 |
Why?
|
Gases | 2 | 2016 | 204 | 0.140 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 386 | 0.140 |
Why?
|
Nitrogen Compounds | 1 | 2017 | 6 | 0.140 |
Why?
|
Fertilizers | 1 | 2017 | 24 | 0.140 |
Why?
|
Arabidopsis Proteins | 1 | 2019 | 264 | 0.140 |
Why?
|
Aged | 28 | 2020 | 169292 | 0.140 |
Why?
|
Glomerular Filtration Rate | 2 | 2018 | 2182 | 0.140 |
Why?
|
Renal Artery | 1 | 2018 | 351 | 0.140 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 26072 | 0.140 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2017 | 69 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 220 | 0.140 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4242 | 0.140 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 319 | 0.140 |
Why?
|
Dengue | 1 | 2020 | 254 | 0.140 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1885 | 0.130 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2112 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2013 | 12159 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8519 | 0.130 |
Why?
|
Personnel, Hospital | 1 | 2018 | 285 | 0.130 |
Why?
|
Triglycerides | 3 | 2015 | 2457 | 0.130 |
Why?
|
Vidarabine | 1 | 2017 | 336 | 0.130 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1275 | 0.130 |
Why?
|
Insulin Resistance | 5 | 2015 | 3952 | 0.130 |
Why?
|
Diet, Reducing | 2 | 2010 | 485 | 0.130 |
Why?
|
Carmustine | 1 | 2016 | 137 | 0.130 |
Why?
|
Osteopontin | 1 | 2018 | 302 | 0.130 |
Why?
|
Vena Cava Filters | 1 | 2019 | 261 | 0.130 |
Why?
|
Adolescent | 15 | 2018 | 88300 | 0.130 |
Why?
|
Plant Diseases | 1 | 2017 | 180 | 0.130 |
Why?
|
Competency-Based Education | 1 | 2017 | 222 | 0.130 |
Why?
|
Arabidopsis | 1 | 2019 | 466 | 0.130 |
Why?
|
Plants | 1 | 2017 | 329 | 0.120 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 648 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 2017 | 350 | 0.120 |
Why?
|
Phylogeny | 2 | 2013 | 2809 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2019 | 589 | 0.120 |
Why?
|
Chlorthalidone | 2 | 2012 | 21 | 0.120 |
Why?
|
Evolution, Molecular | 2 | 2014 | 1882 | 0.120 |
Why?
|
Aneurysm, Ruptured | 1 | 2020 | 464 | 0.120 |
Why?
|
Curriculum | 2 | 2019 | 3741 | 0.120 |
Why?
|
Lisinopril | 2 | 2012 | 60 | 0.120 |
Why?
|
Amlodipine | 2 | 2012 | 84 | 0.120 |
Why?
|
Electrocoagulation | 1 | 2015 | 151 | 0.120 |
Why?
|
Genotype | 3 | 2014 | 12985 | 0.120 |
Why?
|
Enzymes | 1 | 2016 | 252 | 0.120 |
Why?
|
Melphalan | 1 | 2016 | 420 | 0.110 |
Why?
|
Expressed Sequence Tags | 1 | 2014 | 250 | 0.110 |
Why?
|
Obesity, Morbid | 4 | 2014 | 1278 | 0.110 |
Why?
|
Prevalence | 4 | 2012 | 15721 | 0.110 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2015 | 244 | 0.110 |
Why?
|
Thrombectomy | 1 | 2019 | 703 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20982 | 0.110 |
Why?
|
Disaster Medicine | 1 | 2014 | 71 | 0.110 |
Why?
|
Caloric Restriction | 1 | 2016 | 299 | 0.110 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 353 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2020 | 877 | 0.110 |
Why?
|
Glutamate Synthase | 1 | 2013 | 3 | 0.110 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2018 | 698 | 0.110 |
Why?
|
Nitrate Reductase | 1 | 2013 | 11 | 0.110 |
Why?
|
Fires | 1 | 2015 | 171 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1204 | 0.110 |
Why?
|
Logistic Models | 5 | 2018 | 13249 | 0.110 |
Why?
|
Urinary Fistula | 1 | 2013 | 42 | 0.110 |
Why?
|
Species Specificity | 2 | 2014 | 2406 | 0.110 |
Why?
|
Retrospective Studies | 19 | 2023 | 80675 | 0.110 |
Why?
|
Guaiacol | 1 | 2012 | 5 | 0.110 |
Why?
|
Ureteral Diseases | 1 | 2013 | 63 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2020 | 58952 | 0.100 |
Why?
|
Capillary Leak Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
Mass Casualty Incidents | 1 | 2015 | 179 | 0.100 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2493 | 0.100 |
Why?
|
Moths | 1 | 2012 | 81 | 0.100 |
Why?
|
Anticoagulants | 2 | 2019 | 4795 | 0.100 |
Why?
|
Diaphragm | 1 | 2014 | 351 | 0.100 |
Why?
|
Neoplasms | 2 | 2012 | 22142 | 0.100 |
Why?
|
Remission Induction | 1 | 2018 | 2392 | 0.100 |
Why?
|
Absorptiometry, Photon | 3 | 2014 | 1738 | 0.100 |
Why?
|
Biliary Fistula | 1 | 2012 | 37 | 0.100 |
Why?
|
Body Fat Distribution | 1 | 2013 | 245 | 0.100 |
Why?
|
Rats, Inbred Dahl | 1 | 2011 | 34 | 0.100 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2012 | 75 | 0.100 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1182 | 0.100 |
Why?
|
Transcription Factors | 3 | 2019 | 12101 | 0.100 |
Why?
|
Gene Library | 1 | 2014 | 1054 | 0.100 |
Why?
|
Vascular Surgical Procedures | 2 | 2017 | 1489 | 0.100 |
Why?
|
Citrate (si)-Synthase | 1 | 2011 | 48 | 0.100 |
Why?
|
Leadership | 2 | 2018 | 1385 | 0.100 |
Why?
|
Ascites | 1 | 2013 | 338 | 0.100 |
Why?
|
Blast Injuries | 1 | 2015 | 322 | 0.100 |
Why?
|
Signal Transduction | 3 | 2018 | 23419 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2018 | 1488 | 0.090 |
Why?
|
Databases, Factual | 7 | 2020 | 7965 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2014 | 289 | 0.090 |
Why?
|
Self Concept | 1 | 2017 | 1046 | 0.090 |
Why?
|
Appendectomy | 1 | 2015 | 434 | 0.090 |
Why?
|
Sexual Maturation | 1 | 2013 | 261 | 0.090 |
Why?
|
Patient Transfer | 1 | 2018 | 794 | 0.090 |
Why?
|
Crime | 1 | 2012 | 204 | 0.090 |
Why?
|
Pleural Diseases | 1 | 2012 | 137 | 0.090 |
Why?
|
Recurrence | 3 | 2020 | 8457 | 0.090 |
Why?
|
Carotid Stenosis | 1 | 2018 | 859 | 0.090 |
Why?
|
Ontario | 1 | 2012 | 398 | 0.090 |
Why?
|
Sex Factors | 3 | 2020 | 10553 | 0.090 |
Why?
|
Survival Rate | 3 | 2021 | 12728 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6819 | 0.090 |
Why?
|
Abdominal Injuries | 1 | 2014 | 361 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1005 | 0.090 |
Why?
|
Methotrexate | 1 | 2017 | 1718 | 0.090 |
Why?
|
Minority Groups | 1 | 2018 | 1201 | 0.090 |
Why?
|
Lipolysis | 1 | 2011 | 210 | 0.090 |
Why?
|
Fistula | 1 | 2012 | 212 | 0.090 |
Why?
|
Telemetry | 1 | 2011 | 199 | 0.090 |
Why?
|
Exercise | 2 | 2021 | 5874 | 0.090 |
Why?
|
Kidney | 2 | 2018 | 7033 | 0.090 |
Why?
|
Shock | 1 | 2012 | 314 | 0.090 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2692 | 0.090 |
Why?
|
Malaria | 1 | 2020 | 1225 | 0.090 |
Why?
|
Tonometry, Ocular | 1 | 2011 | 236 | 0.090 |
Why?
|
Tea | 1 | 2011 | 288 | 0.090 |
Why?
|
Television | 1 | 2013 | 407 | 0.090 |
Why?
|
Hepatic Encephalopathy | 1 | 2011 | 143 | 0.080 |
Why?
|
Lipids | 2 | 2011 | 3331 | 0.080 |
Why?
|
Mitochondria, Muscle | 1 | 2011 | 172 | 0.080 |
Why?
|
Hernia, Ventral | 1 | 2013 | 218 | 0.080 |
Why?
|
Intraoperative Period | 1 | 2011 | 510 | 0.080 |
Why?
|
Abdomen | 1 | 2016 | 1128 | 0.080 |
Why?
|
Methylation | 1 | 2012 | 1070 | 0.080 |
Why?
|
Fruit | 1 | 2015 | 1158 | 0.080 |
Why?
|
Colectomy | 1 | 2015 | 686 | 0.080 |
Why?
|
Cation Transport Proteins | 1 | 2012 | 324 | 0.080 |
Why?
|
Lung Injury | 1 | 2014 | 422 | 0.080 |
Why?
|
Ischemia | 1 | 2018 | 1889 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 602 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2011 | 349 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39127 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13632 | 0.080 |
Why?
|
Warfarin | 1 | 2017 | 1482 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2863 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11733 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2018 | 4373 | 0.080 |
Why?
|
Cell Hypoxia | 1 | 2011 | 656 | 0.080 |
Why?
|
Lens, Crystalline | 1 | 2011 | 385 | 0.080 |
Why?
|
Linear Models | 3 | 2014 | 5869 | 0.080 |
Why?
|
PPAR gamma | 1 | 2011 | 483 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2012 | 1768 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1448 | 0.080 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2011 | 263 | 0.080 |
Why?
|
Light | 1 | 2014 | 1348 | 0.080 |
Why?
|
Appendicitis | 1 | 2015 | 676 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2244 | 0.080 |
Why?
|
Sequence Alignment | 1 | 2012 | 2175 | 0.080 |
Why?
|
Resuscitation | 1 | 2012 | 672 | 0.070 |
Why?
|
Adenovirus Infections, Human | 1 | 2008 | 73 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2019 | 2877 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10756 | 0.070 |
Why?
|
Selection, Genetic | 1 | 2012 | 871 | 0.070 |
Why?
|
Leptin | 2 | 2016 | 1595 | 0.070 |
Why?
|
Indiana | 2 | 2018 | 92 | 0.070 |
Why?
|
Lactic Acid | 1 | 2013 | 1139 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1741 | 0.070 |
Why?
|
Helicobacter pylori | 1 | 2011 | 382 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 609 | 0.070 |
Why?
|
Troponin T | 1 | 2012 | 780 | 0.070 |
Why?
|
Helicobacter Infections | 1 | 2011 | 392 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 620 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1812 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1212 | 0.070 |
Why?
|
Myocardial Infarction | 3 | 2020 | 11476 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1923 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2020 | 588 | 0.070 |
Why?
|
Child, Preschool | 7 | 2018 | 42225 | 0.060 |
Why?
|
Child | 8 | 2018 | 80154 | 0.060 |
Why?
|
Comorbidity | 2 | 2011 | 10516 | 0.060 |
Why?
|
General Surgery | 1 | 2017 | 1693 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3778 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4947 | 0.060 |
Why?
|
HIV Infections | 1 | 2012 | 17348 | 0.060 |
Why?
|
Luminescence | 2 | 2016 | 108 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8642 | 0.060 |
Why?
|
Cholesterol | 2 | 2015 | 2902 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4567 | 0.060 |
Why?
|
Double-Blind Method | 6 | 2018 | 12341 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3220 | 0.060 |
Why?
|
Postoperative Complications | 6 | 2023 | 15637 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3025 | 0.060 |
Why?
|
Intraocular Pressure | 1 | 2011 | 1294 | 0.060 |
Why?
|
Overweight | 2 | 2013 | 2418 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4612 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2254 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12052 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4340 | 0.060 |
Why?
|
Explosions | 2 | 2015 | 107 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5665 | 0.060 |
Why?
|
Adipocytes | 1 | 2011 | 1190 | 0.060 |
Why?
|
Adenoviridae | 1 | 2008 | 1084 | 0.060 |
Why?
|
Biological Assay | 1 | 2007 | 623 | 0.060 |
Why?
|
Reoperation | 2 | 2013 | 4303 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1164 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4921 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2012 | 1156 | 0.060 |
Why?
|
Social Class | 1 | 2012 | 1993 | 0.050 |
Why?
|
Fatty Acids | 1 | 2011 | 1807 | 0.050 |
Why?
|
Proteome | 1 | 2013 | 1856 | 0.050 |
Why?
|
Ultrasonography | 2 | 2016 | 5969 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17598 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1920 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1388 | 0.050 |
Why?
|
Fatty Liver | 1 | 2009 | 789 | 0.050 |
Why?
|
Age Distribution | 2 | 2020 | 2871 | 0.050 |
Why?
|
Animals | 8 | 2014 | 168089 | 0.050 |
Why?
|
Seeds | 2 | 2014 | 122 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3620 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5321 | 0.050 |
Why?
|
Glucose | 2 | 2011 | 4342 | 0.050 |
Why?
|
Risk Assessment | 4 | 2023 | 24022 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2011 | 1670 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2010 | 1375 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4788 | 0.050 |
Why?
|
Stroke | 3 | 2020 | 9721 | 0.050 |
Why?
|
Registries | 2 | 2018 | 8246 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2092 | 0.050 |
Why?
|
Health Care Costs | 1 | 2014 | 3239 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13402 | 0.040 |
Why?
|
Poverty | 1 | 2012 | 2691 | 0.040 |
Why?
|
Suicide | 1 | 2012 | 1602 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2011 | 1932 | 0.040 |
Why?
|
Cohort Studies | 5 | 2017 | 41496 | 0.040 |
Why?
|
United States | 6 | 2023 | 72341 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2631 | 0.040 |
Why?
|
Insulin | 2 | 2015 | 6588 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1347 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5842 | 0.040 |
Why?
|
Rats | 2 | 2014 | 23705 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3907 | 0.040 |
Why?
|
Anaerobiosis | 1 | 2019 | 139 | 0.040 |
Why?
|
Quinazolinones | 1 | 2021 | 221 | 0.040 |
Why?
|
Acrylamides | 1 | 2021 | 259 | 0.040 |
Why?
|
Collagen Type V | 1 | 2018 | 16 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 362 | 0.040 |
Why?
|
Intra-Abdominal Fat | 2 | 2014 | 612 | 0.040 |
Why?
|
Diet | 1 | 2016 | 8048 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2014 | 18222 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12747 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10707 | 0.040 |
Why?
|
Phlebography | 1 | 2019 | 326 | 0.040 |
Why?
|
Research Design | 2 | 2014 | 6180 | 0.040 |
Why?
|
Primary Health Care | 2 | 2014 | 4679 | 0.040 |
Why?
|
Boston | 3 | 2015 | 9327 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2756 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5885 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2012 | 4487 | 0.030 |
Why?
|
Drug Therapy, Combination | 3 | 2013 | 6304 | 0.030 |
Why?
|
Elastin | 1 | 2018 | 298 | 0.030 |
Why?
|
Tissue Culture Techniques | 2 | 2008 | 289 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 281 | 0.030 |
Why?
|
Narcotic Antagonists | 2 | 2013 | 585 | 0.030 |
Why?
|
Fluid Shifts | 1 | 2016 | 20 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 527 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13386 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20588 | 0.030 |
Why?
|
Prospective Studies | 3 | 2020 | 54437 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2020 | 947 | 0.030 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2016 | 33 | 0.030 |
Why?
|
Varicose Veins | 1 | 2017 | 156 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9979 | 0.030 |
Why?
|
Vascular Patency | 1 | 2018 | 911 | 0.030 |
Why?
|
Hypertrophy | 1 | 2017 | 558 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 1073 | 0.030 |
Why?
|
Limb Salvage | 1 | 2018 | 480 | 0.030 |
Why?
|
Seed Storage Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6486 | 0.030 |
Why?
|
Plant Shoots | 1 | 2014 | 26 | 0.030 |
Why?
|
Louisiana | 1 | 2014 | 103 | 0.030 |
Why?
|
Peritoneal Lavage | 1 | 2014 | 30 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1046 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 781 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 637 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1518 | 0.030 |
Why?
|
Fasting | 2 | 2011 | 1603 | 0.030 |
Why?
|
Holidays | 1 | 2013 | 40 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6417 | 0.030 |
Why?
|
Hernia, Diaphragmatic | 1 | 2014 | 244 | 0.030 |
Why?
|
Anthocyanins | 1 | 2013 | 80 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1897 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6506 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4015 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2277 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2013 | 208 | 0.030 |
Why?
|
Rupture | 1 | 2014 | 443 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2016 | 1128 | 0.030 |
Why?
|
Biosynthetic Pathways | 1 | 2013 | 136 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1176 | 0.030 |
Why?
|
Sexual Behavior, Animal | 1 | 2013 | 120 | 0.030 |
Why?
|
Balloon Occlusion | 1 | 2013 | 125 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2570 | 0.020 |
Why?
|
Thoracostomy | 1 | 2012 | 74 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2014 | 753 | 0.020 |
Why?
|
Motor Activity | 2 | 2013 | 2712 | 0.020 |
Why?
|
Hematuria | 1 | 2013 | 232 | 0.020 |
Why?
|
Tinidazole | 1 | 2011 | 2 | 0.020 |
Why?
|
Leisure Activities | 1 | 2013 | 308 | 0.020 |
Why?
|
Hyperemia | 1 | 2012 | 225 | 0.020 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2011 | 32 | 0.020 |
Why?
|
Diastole | 1 | 2013 | 782 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3418 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2011 | 208 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2013 | 580 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15308 | 0.020 |
Why?
|
Puerto Rico | 1 | 2012 | 378 | 0.020 |
Why?
|
Rib Fractures | 1 | 2012 | 128 | 0.020 |
Why?
|
Clarithromycin | 1 | 2011 | 86 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1702 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 162 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1747 | 0.020 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2013 | 489 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1122 | 0.020 |
Why?
|
Educational Measurement | 1 | 2017 | 1250 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22174 | 0.020 |
Why?
|
Ammonia | 1 | 2011 | 243 | 0.020 |
Why?
|
Ceramides | 1 | 2011 | 200 | 0.020 |
Why?
|
Chemokines | 1 | 2014 | 956 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 961 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36415 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 667 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2393 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 18927 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4111 | 0.020 |
Why?
|
Adipogenesis | 1 | 2011 | 368 | 0.020 |
Why?
|
Upper Extremity | 1 | 2013 | 658 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 110 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9319 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2014 | 820 | 0.020 |
Why?
|
Doxazosin | 1 | 2008 | 18 | 0.020 |
Why?
|
Anilides | 1 | 2011 | 411 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2981 | 0.020 |
Why?
|
Ghrelin | 1 | 2010 | 251 | 0.020 |
Why?
|
Device Removal | 1 | 2013 | 629 | 0.020 |
Why?
|
Mice, Obese | 1 | 2008 | 418 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5250 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3808 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15841 | 0.020 |
Why?
|
Angiogenesis Modulating Agents | 1 | 2007 | 8 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1302 | 0.020 |
Why?
|
Oxygen | 1 | 2019 | 4228 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21366 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5478 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1217 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3803 | 0.020 |
Why?
|
Lipectomy | 1 | 2008 | 113 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 801 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2125 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 1603 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1847 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2013 | 680 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11119 | 0.020 |
Why?
|
Lower Extremity | 1 | 2013 | 1201 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6223 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3422 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2374 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2227 | 0.020 |
Why?
|
Critical Illness | 1 | 2018 | 2724 | 0.020 |
Why?
|
Thrombin | 1 | 2007 | 593 | 0.010 |
Why?
|
Qualitative Research | 1 | 2015 | 3024 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2008 | 836 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10218 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2018 | 5295 | 0.010 |
Why?
|
Fibrinogen | 1 | 2007 | 888 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2035 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5755 | 0.010 |
Why?
|
Exercise Test | 1 | 2011 | 2165 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1055 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8164 | 0.010 |
Why?
|
Patient Readmission | 1 | 2017 | 3265 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2092 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4739 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12976 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3044 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6974 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3763 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3061 | 0.010 |
Why?
|
Communication | 1 | 2015 | 3872 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9652 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10203 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8837 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2013 | 3744 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2012 | 3410 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3840 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2478 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2864 | 0.010 |
Why?
|
Placenta | 1 | 2007 | 1711 | 0.010 |
Why?
|
Coronary Disease | 1 | 2012 | 5921 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12474 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2008 | 3149 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2008 | 2893 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30004 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81330 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9458 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20118 | 0.000 |
Why?
|
Heart Failure | 1 | 2012 | 11701 | 0.000 |
Why?
|